摘要
背景:认知训练是一种基于一系列反映特定认知功能的任务的非药理学干预。CT旨在提高认知患者的认知能力。虽然目前还没有明确的结论表明它在阿尔茨海默病(AD)中的作用。 目的:评价一种旨在提高AD患者认知能力的CT程序的有效性。 方法:采用随机、对照、单盲、纵向试验的方法,对轻度至中度AD患者进行无治疗对照试验.。治疗组每周接受CT两次,共6次。HS,而对照组没有。CT包括从纸和铅笔到口头学习练习的任务。参与者的认知水平在基线、干预后和6个月时进行评估。后来通过一组完整的神经心理学测试。采用重复测量方差分析时间对观察指标的影响,并比较治疗组和未治疗组的疗效。NTS随着时间的推移,人口数据被视为协变量。 结果:140例患者中,治疗组45例,对照组85例。CT治疗后即刻认知功能明显改善。六摩后来,一些测试分数与基线时相比保持稳定。对照组在每一时间点上的表现都明显低于治疗组,显示出一个进程。随着时间的推移,认知能力下降。 结论:CT可改善AD患者的认知功能,并可暂时延缓认知功能下降。
关键词: 阿尔茨海默病,认知训练,认知刺激,非药物干预,神经心理学评估,随机对照试验(RCT)。
Current Alzheimer Research
Title:Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial
Volume: 15 Issue: 5
关键词: 阿尔茨海默病,认知训练,认知刺激,非药物干预,神经心理学评估,随机对照试验(RCT)。
摘要: Background: Cognitive training (CT) is a non-pharmacological intervention based on a set of tasks that reflect specific cognitive functions. CT is aimed at improving cognition in patients with cognitive impairment, though no definitive conclusions have yet been drawn on its efficacy in Alzheimer's disease (AD).
Objective: To assess the effectiveness of a CT program designed to improve cognition in AD patients.
Method: This is a randomized, controlled, single-blind, longitudinal trial with a no-treatment control condition in mild-to-moderate AD. Treated patients received in-group CT twice a week for six months, whereas controls did not. CT consisted of tasks ranging from paper-and-pencil to verbal-learning exercises. Participants' cognitive levels were assessed at baseline, post-intervention and 6 months later by means of a complete neuropsychological test battery. Repeated measures ANOVA was used to analyze the effect of time on the outcome measures, as well as to compare treated and untreated patients over time, with demographic data considered as covariates.
Results: Of the 140 patients enrolled, 45 in the treated group and 85 controls concluded the study. The CT significantly improved treated subjects' cognitive functions immediately after the CT. Six months later, some test scores remained stable when compared with those obtained at baseline. The control group performed significantly worse than the treated group at each time-point, displaying a progressive cognitive decline over time.
Conclusion: Our results suggest that CT may improve cognitive functions in patients with AD and may help to temporarily slow their cognitive decline.
Export Options
About this article
Cite this article as:
Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial, Current Alzheimer Research 2018; 15 (5) . https://dx.doi.org/10.2174/1567205014666171113105044
DOI https://dx.doi.org/10.2174/1567205014666171113105044 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Insulin Resistance, Glycemic Control and Adiposity: Key Determinants of Healthy Lifespan
Current Alzheimer Research Current Status of Anti-HIV Agents
Current Medicinal Chemistry - Anti-Infective Agents Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Association of Red Blood Cell Indices with Mild Cognitive Impairment in Chinese Elderly Individuals: A Matched Case-control Study
Current Alzheimer Research Neurobiology of Sleep Fragmentation: Cortical and Autonomic Markers of Sleep Disorders
Current Pharmaceutical Design Editorial (Thematic Issue:Drug-eluting Stents and Concomitant Treatment)
Cardiovascular & Hematological Disorders-Drug Targets The Interactions Between Alzheimer’s Disease and Major Depression: Role of Ca<sup>2+</sup> Channel Blockers and Ca<sup>2+</sup>/cAMP Signalling
Current Drug Research Reviews Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design Neurodegeneration and Neurogenesis: Focus on Alzheimers Disease
Current Alzheimer Research Maternal Vitamin D Status and Development of Asthma and Allergy in Early Childhood
Mini-Reviews in Medicinal Chemistry Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Translational Challenge Models in Support of Efficacy Studies: Effect of Cerebral Hypoxia on Cognitive Performances in Rodents
CNS & Neurological Disorders - Drug Targets Responses of Glial Cells to Stress and Glucocorticoids
Current Immunology Reviews (Discontinued) Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Fatty Acids in the Regulation of Cerebral Vascular Function and Neuroprotection in Ischemia
CNS & Neurological Disorders - Drug Targets Role of Inflammatory Markers in Elderly Type 2 Diabetic Patients with Mild Cognitive Impairment
Current Diabetes Reviews The Triad: Erectile Dysfunction - Endothelial Dysfunction - Cardiovascular Disease
Current Pharmaceutical Design Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease
Current Drug Targets An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer’s: A Review
Medicinal Chemistry Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets